ACME UNITED CORP - 10-Q Summary (Q1 2025)
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2025. Acme United Corporation manufactures and distributes first aid, medical, cutting, and sharpening products. The company operates in three reportable segments: United States, Canada, and Europe. It is classified as an accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Sales | $45,958,000 | $44,956,000 |
| Gross Profit | $17,917,000 (39.0% margin) | $17,396,000 (38.7% margin) |
| Operating Income | $2,426,000 | $2,558,000 |
| Net Income | $1,653,000 | $1,636,000 |
| Diluted EPS | $0.41 | $0.39 |
| Cash and Equivalents | $3,446,000 | $3,193,000 |
| Long-Term Debt | $20,428,000 | $17,606,000 |
| Working Capital | $76,776,000 | $72,588,000 |
| Current Ratio | 4.83 | 4.17 |
Cash Flow: Net cash used in operating activities was $3,337,000, compared to $10,168,000 used in Q1 2024. Net cash provided by financing activities was $1,691,000, driven by net borrowings of $2,816,000.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 2% year-over-year. The U.S. segment grew 3%, driven by first aid and medical products, while school and office products declined due to a large one-time order in Q1 2024. Canada sales rose 5% (USD) / 12% (local currency). Europe sales declined 7% (USD) due to a non-recurring promotion in the prior year.
- Profitability: Gross margin improved slightly to 39.0%. Operating income decreased 5% to $2.426 million, primarily due to a $154,000 decline in European operating income and higher SG&A expenses ($15.491M vs $14.838M) driven by personnel costs.
- Debt: Long-term debt increased by approximately $2.8 million due to increased borrowings under the revolving credit facility to support operations.
- Inventory: Inventory levels rose to $57.274 million from $56.254 million.
Outlook, Risks, and Unusual Items
- Tariff Risks: Management highlights significant risk from a new 145% tariff on goods sourced from China, which could increase costs and disrupt supply chains. The company plans to mitigate this via strategic sourcing and price adjustments.
- Internal Controls: The company disclosed a material weakness in internal controls over financial reporting related to IT general controls (logical security and privileged access). Management has implemented remediation steps and expects the weakness to be resolved by December 31, 2025.
- Acquisition Contingency: Following the acquisition of Elite First Aid, $500,000 of the purchase price is contingent on revenue milestones through December 31, 2025.
- Seasonality: The company notes that Q1 is traditionally a weaker quarter due to the seasonal nature of the back-to-school market.
Investor Verification Checklist
- Verify the timeline and testing results for the remediation of the material weakness in IT general controls.
- Monitor the impact of the 145% China tariff on cost of goods sold and gross margins in subsequent quarters.
- Review the performance of the European segment to determine if the sales decline is a temporary anomaly or a structural trend.
- Assess the utilization of the $65 million revolving credit facility and the company's ability to service the increased debt load.
- Confirm the achievement of revenue milestones required to release the $500,000 contingent consideration for the Elite First Aid acquisition.